Phase 2 Cardiogenic Shock Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Physiology of Unloading VA ECMO Trial
Cardiogenic Shock
University of Utah104 enrolled1 locationNCT06336655
Recruiting
Phase 2
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
Heart FailureCardiomyopathiesCardiogenic Shock+1 more
Stanford University50 enrolled5 locationsNCT06080074
Recruiting
Phase 2
Cangrelor on Top of anticoagUlation in Patients With myocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest receiVIng VA-ECMO
Cardiogenic ShockExtracorporeal Membrane Oxygenation ComplicationPlatelet Dysfunction
IRCCS San Raffaele50 enrolled1 locationNCT06792643
Recruiting
Phase 2
REMAP ECMO - Beta Receptor Modulation Trial
Heart FailureCardiogenic Shock
Erasmus Medical Center20 enrolled1 locationNCT06522594